Antonio ‘Bigfoot’ Silva fails post-fight drug test, stripped of $50,000 bonus


Despite gaining approval for the use of testosterone replacement therapy, Antonio Silva still failed his post-fight drug test following a “Fight of the Year” candidate against Mark Hunt in the headliner of UFC Fight Night 33.Filed under: MMA Rumors, News, Only on (...) view original article >>
Report here if this news is invalid.

Related News

  • 15 days ago
  • 0 views

Japanese UFC prospect Michinori Tanaka failed his post-fight drug test after taking over-the-counter allergy meds. Michinori Tanaka fought a fellow star from the Asian circuit in Kyung Ho Kang last S read news >>

  • 11 days ago
  • 0 views

Read on to find out who took home bonuses from UFC 181 read news >>

  • 8 days ago
  • 6 views

Frank Mir looks ahead to his return to the UFC next year against Antonio Silva. read news >>

  • 5 days ago
  • 0 views

Read on to find out who took home bonuses from The Ultimate Fighter Finale. read news >>

  • 27 days ago
  • 2 views

UFC middleweight title challenger Vitor Belfort passed a random drug test administered by the Nevada State Athletic Commission in advance of his February title fight against champ Chris Weidman.Filed read news >>

  • 27 days ago
  • 1 views

UFC middleweight title challenger Vitor Belfort has passed a random drug test administered to him by Nevada's Athletic Commission earlier this month. The leading storyline in the build-up to Chris We read news >>

  • 27 days ago
  • 11 views

Vitor Belfort passed the first of what is expected to be many random drug tests ahead of his upcoming UFC 184 title challenge against middleweight champion Chris Weidman, MMAFighting.com confirmed wi read news >>

  • 27 days ago
  • 2 views

Vitor Belfort has cleared the first of what is likely to be several hurdles leading up to his UFC 184 title challenge of middleweight champion Chris Weidman. read news >>

  • 26 days ago
  • 0 views

Vitor Belfort passed a random drug test submitted to the Nevada Athletic Commission on Nov. 1. read news >>

Jump to: